Earnings in 4d
Genenta Science (ADR)
Develops tumor-targeted gene therapy and staged Italian defense and aerospace investments.
$1.00
After-hours close−0.01 (−0.99%)
At close$1.01(+1.95%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Sep 2026 | −$0.27 | — | — |
| Mar 2026 | −$0.36 | −$0.36 | 0.0% |
| Feb 2026 | −$0.36 | −$0.36 | 0.0% |
| Mar 2025 | −$0.26 | — | — |
| Jun 2024 | — | −$0.24 | — |
| Apr 2024 | −$0.42 | −$0.30 | +29.7% |
The latest year is open to everyone — the 9 quarters behind it read with an account. Sign in | |||
| Jun 2023 | |||
| Apr 2023 | |||
| Oct 2022 | |||
| May 2022 | |||
| Dec 2021 | |||
| Dec 2020 | |||
| Jun 2020 | |||
| Dec 2019 | |||
| Jun 2019 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | −$0.27 | — | — | — | — | — |
| Mar 31, 2026 | −$0.36 | −$0.36 | 0.0% | — | — | — |
| Feb 25, 2026 | −$0.36 | −$0.36 | 0.0% | — | — | — |
| Mar 28, 2025 | −$0.26 | — | — | — | — | — |
| Jun 30, 2024 | — | −$0.24 | — | — | — | — |
| Apr 24, 2024 | −$0.42 | −$0.30 | +29.7% | — | $5.5M | — |
The latest year is open to everyone — the 9 quarters behind it read with an account. Sign in | ||||||
| Jun 30, 2023 | ||||||
| Apr 26, 2023 | ||||||
| Oct 7, 2022 | ||||||
| May 4, 2022 | ||||||
| Dec 15, 2021 | ||||||
| Dec 31, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Dec 31, 2019 | ||||||
| Jun 30, 2019 | ||||||